RESUMEN
The global population is undergoing rapid aging, making physical activity a crucial element in preventing mortality and lowering the risk of Alzheimer's disease. Age-related declines in muscle mass and cognitive abilities significantly contribute to frailty and dependency. Thus, this study focuses on a meticulous analysis of the protective effects of multidomain interventions, an emerging resource combating age-related declines. It seeks to underscore their profound impact on cognitive flexibility and sarcopenia, highlighting their pivotal role in mitigating the adverse effects of aging. To identify relevant randomized controlled trials up to November 2023, we reviewed eight online academic databases, following PERSiST guidelines, PRISMA reporting system, and PICOs criteria. Meta-analyses on selected functional outcomes utilized a random-effects model, including the Timed Up and Go Test, Sit to Stand Test, Victoria Stroop Test, and Trail Making Test. Out of 2082 scrutinized articles, 17 were included in the systematic review, and 8 in the meta-analysis. Positive effects (p = 0.05, I2 = 57%; 95% CI - 0.63 to - 0.05) were observed in cognitive flexibility for certain interventions. Similarly, interventions addressing muscle strength demonstrated improvements in the Sit to Stand Test for the exercise group compared to the control group (p = 0.02, I2 = 0%; 95% CI - 0.63 to - 0.05). These findings underscore the importance of incorporating physical activity as a primary component of public health interventions for promoting healthy aging and reducing the burden of age-related diseases. Future interventions may explore more homogeneous approaches and evaluate the impact of thrice multidomain weekly sessions.
Asunto(s)
Cognición , Envejecimiento Saludable , Sarcopenia , Anciano , Humanos , Cognición/fisiología , Ejercicio Físico/fisiología , Envejecimiento Saludable/fisiología , Fuerza Muscular/fisiología , Ensayos Clínicos Controlados Aleatorios como Asunto , Sarcopenia/prevención & controlRESUMEN
This article examines patterns of legal American immigration (migrations to the United States from abroad) and their direct impact on the acquisition of neuropsychological (NP) normative data for Hispanics. The nonrandom and selective nature of these migrations, and their accompanying demographic attributes, are shown to significantly influence the acquisition process. Specifically, the direct impact of several potential sources of bias while procuring NP norms is explored. Total number of immigrants (absolute immigration), occupational allegiance (and possibly education), and intended area of initial residence seem to play influential roles as a result of their direct impact on demographic characteristics known to have significant effects on neuropsychological performance. Possible solutions capable of enhancing the acquisition process are also addressed.
RESUMEN
Psychometric properties of the Test of Variables of Attention (TOVA) were examined in a cohort of children (n=63) strictly diagnosed with attention-deficit/hyperactivity disorder (AD/HD). Internal consistency was assessed via correlational analyses to determine the degree of agreement among various test portions. The temporal stability of errors of omission, errors of commission, response time, and response time variability was evaluated using test-retest reliability. Reproducibility of individual scores for the same indices was assessed using the Bland-Altman procedure. Select TOVA index scores exhibited high internal consistency in this cohort. Although the temporal stability of group scores (test-retest reliability) was satisfactory, individual test scores were less reproducible. Temporal stability and individual test-retest score agreement were greater for response time and response time variability than for errors of omission and errors of commission.
RESUMEN
Magnetic resonance imaging is a promising technological advance used for research and diagnosis of disease. The procedure has no risks, except when uncooperative patients require sedation. Four normal children participated in simulated scans to study the effects of (a) antecedent changes in the imaging environment and (b) operant conditioning of movement inhibition. Changing the environment can decrease movement, but operant contingencies were necessary to decrease movement to a level that, in most cases, would allow the procedure to occur without sedation.
Asunto(s)
Terapia Conductista/métodos , Imagen por Resonancia Magnética/psicología , Actividad Motora , Cooperación del Paciente/psicología , Niño , Preescolar , Retroalimentación , Femenino , Humanos , Conducta Imitativa , Masculino , Medio SocialRESUMEN
OBJECTIVE: To assess the tolerability of liposomal amphotericin B (L-AmB) in critically ill patients with elevated serum creatinine concentrations (Cr) (> 1.5 mg/dL) at starting L-AmB therapy. METHODS: Retrospective, multicenter, comparative study of two cohorts of critically ill patients treated with L-AmB during 3 or more days, the difference between them was the level of Cr at the beginning of treatment. A cutoff value of Cr of 1.5 mg/dL was established. Patients undergoing extrarenal depuration procedures before or 48 hours after starting L-AmB were excluded. The primary endpoint was the difference between Cr values at the end of treatment as compared with Cr at starting L-AmB. Secondary endpoints were treatment-related withdrawals, need of extrarenal depuration techniques, and treatment-related severe adverse events. Demographic data, underlying illness, indication of L-AmB therapy, concomitant risk factors of nephrotoxicity, and vital status at ICU and hospital discharge were recorded. RESULTS: A total of 122 patients admitted to 26 ICUs (16 with Cr > 1.5 g/dL; 106 with normal Cr levels) were recruited. Main reasons for the use of L-AmB in both groups were the broad spectrum of the drug and the presence of hemodynamic instability. L-AmB was administered as first-line treatment in 68.8% of patients with elevated Cr and in 52.8% with normal Cr. The APACHE II score on ICU admission was 25 in patients with elevated Cr and 17 in those with normal Cr values (p < 0.001). Duration of treatment with L-AmB was 16 and 12 days in patients with elevate and normal Cr values, respectively, with a mean dose of 3.5 vs 3.9 mg/kg/day. The use of concomitant nephrotoxic drugs, mortality rate, and ICU and hospital length of stay were similar in both cohorts. In patients with renal function impairment at the initiation of L-AmB treatment, an absolute decrease of Cf-Ci of 1.08 mg/dL was observed (P < 0.001). A decrease of Cr levels to normal limits was observed in 50% of the patients; in 37.5% of patients there was a decrease but normal levels were not achieved, whereas a Cr increased occurred in only one (6.25%) patient. None of the patients required withdrawal of L-AmB or use of extrarenal depuration procedures. Treatment-related severe adverse events were not reported. CONCLUSIONS: In critically ill patients with impaired renal function, the impact of L-AmB on renal function was minimal. L-AmB can be used for the treatment of fungal infections in critically ill patients independently of renal function at the initiation of treatment.
Asunto(s)
Anfotericina B/efectos adversos , Antifúngicos/efectos adversos , Enfermedad Crítica/terapia , Enfermedades Renales/complicaciones , Riñón/efectos de los fármacos , Adolescente , Adulto , Anciano , Anciano de 80 o más Años , Anfotericina B/uso terapéutico , Antifúngicos/uso terapéutico , Niño , Preescolar , Estudios de Cohortes , Creatinina/sangre , Femenino , Humanos , Lactante , Pruebas de Función Renal , Masculino , Persona de Mediana Edad , Micosis/complicaciones , Micosis/tratamiento farmacológico , Estudios Retrospectivos , Adulto JovenRESUMEN
Compartment syndrome of the lower leg is an occasional complication of prolonged ischemia and reperfusion. We present a patient with compartment syndrome of the ipsilateral thigh after femoral arterial and venous cannulation for cardiopulmonary bypass.
Asunto(s)
Puente Cardiopulmonar/efectos adversos , Síndromes Compartimentales/etiología , Pierna/irrigación sanguínea , Niño , Femenino , HumanosRESUMEN
Differences in neuropsychological performance associated with specific test presentation sequences have been reported in adults. However, these effects have received little attention in children. The EOWPVT-R, a measure of one-word expressive language, and the PPVT-R, a measure of receptive language, were administered to 6- to 14-year-olds (control [n = 17] and experimental [n = 22] groups) in a counterbalanced fashion to investigate the potential effects of test presentation sequence on neuropsychological performance. Group findings were not evidenced subsequent to variation in test administration sequence. In contrast, order of test presentation revealed differences in performance. Administration of the PPVT-R prior to the EOWPVT-R resulted in enhanced EOWPVT-R expressive language scores in both groups of participants. Presentation of the PPVT-R after the EOWPVT-R did not affect performance. Applied and theoretical implications associated with these findings are discussed.
Asunto(s)
Enfermedades Virales del Sistema Nervioso Central/psicología , Infecciones por Citomegalovirus/psicología , Trastornos del Desarrollo del Lenguaje/psicología , Trastornos del Desarrollo del Lenguaje/virología , Pruebas del Lenguaje/normas , Adolescente , Estudios de Casos y Controles , Enfermedades Virales del Sistema Nervioso Central/congénito , Niño , Señales (Psicología) , Infecciones por Citomegalovirus/congénito , Femenino , Humanos , Masculino , Práctica Psicológica , PsicometríaRESUMEN
OBJECTIVE: To determine the effect of stimulant medications used to treat children with attention-deficit/hyperactivity disorder (AD/HD) on energy expenditure, fuel utilization, and physical activity. STUDY DESIGN: Energy expenditure and physical activity were measured, respectively, by room respiration calorimetry and microwave motion detectors in 31 children with AD/HD (26 boys and 5 girls; ages 6 to 12 years) both while they were receiving their prescribed stimulant medication and after the medication had been discontinued for at least 24 hours. Fuel utilization was calculated from calorimetry data. RESULTS: Total and awake energy expenditure including energy expended while doing schoolwork, riding a stationary bicycle, resting, and watching a movie were from 4% to 8% lower when the children were receiving their prescribed stimulant medication. Total and awake activity were also lower while they were receiving medication (16% to 22%) and accounted for the lower rates of energy expenditure. Sleeping metabolic rate, basal metabolic rate, and fuel utilization were unaffected by medication. CONCLUSIONS: Stimulant medications decrease physical activity, and hence, decrease the activity component of total daily energy expenditure in children with AD/HD.
Asunto(s)
Trastorno por Déficit de Atención con Hiperactividad/tratamiento farmacológico , Estimulantes del Sistema Nervioso Central/farmacología , Metabolismo Energético/efectos de los fármacos , Actividad Motora/efectos de los fármacos , Análisis de Varianza , Calorimetría , Estudios de Casos y Controles , Estimulantes del Sistema Nervioso Central/uso terapéutico , Niño , Dextroanfetamina/análogos & derivados , Dextroanfetamina/uso terapéutico , Femenino , Humanos , Masculino , Metilfenidato/farmacología , Metilfenidato/uso terapéutico , Análisis de RegresiónRESUMEN
OBJECTIVE: To determine whether docosahexaenoic acid (DHA) supplementation for 4 months decreases the symptoms of attention-deficit/hyperactivity disorder (ADHD). STUDY DESIGN: Sixty-three 6- to-12-year-old children with ADHD, all receiving effective maintenance therapy with stimulant medication, were assigned randomly, in a double-blind fashion, to receive DHA supplementation (345 mg/d) or placebo for 4 months. Outcome variables included plasma phospholipid fatty acid patterns, scores on laboratory measures of inattention and impulsivity (Test of Variables of Attention, Children's Color Trails test) while not taking stimulant medication, and scores on parental behavioral rating scales (Child Behavior Checklist, Conners' Rating Scale). Differences between groups after 4 months of DHA supplementation or placebo administration were determined by analysis of variance, controlling for age, baseline value of each outcome variable, ethnicity, and ADHD subtype. RESULTS: Plasma phospholipid DHA content of the DHA-supplemented group was 2.6-fold higher at the end of the study than that of the placebo group (4.85 +/- 1.35 vs 1.86 +/- 0.87 mol % of total fatty acids; P <.001). Despite this, there was no statistically significant improvement in any objective or subjective measure of ADHD symptoms. CONCLUSION: A 4-month period of DHA supplementation (345 mg/d) does not decrease symptoms of ADHD.
Asunto(s)
Trastorno por Déficit de Atención con Hiperactividad/tratamiento farmacológico , Conducta Infantil/efectos de los fármacos , Ácidos Docosahexaenoicos/uso terapéutico , Análisis de Varianza , Niño , Método Doble Ciego , Femenino , Humanos , Masculino , Fosfolípidos/sangreRESUMEN
This investigation examined the effects of HIV-1 infection on speeded complex cognitive processing in a group of HIV-negative (n = 666), HIV-positive symptomatic (n = 156), and HIV-positive asymptomatic (n = 623) participants while controlling for the effects of slowed motor functioning, peripheral neuropathy, and several other putative confounds. Stroop Interference and reaction-time tasks served as anchor procedures to assess cognitive processing. The present findings suggest that HIV-1 infection is capable of compromising CNS-mediated cognitive processes (speeded processing) infringing upon their efficacy in the symptomatic stages of the disease while sparing individuals in the asymptomatic stage. The detrimental effects observed on information-processing mechanisms associated with HIV infection persisted despite the use of procedures to control for peripheral nerve integrity and other potential confounds.
Asunto(s)
Complejo SIDA Demencia/diagnóstico , Atención , VIH-1 , Pruebas Neuropsicológicas , Tiempo de Reacción , Complejo SIDA Demencia/psicología , Adulto , Estudios de Cohortes , Percepción de Color , Aprendizaje Discriminativo , Humanos , Estudios Longitudinales , Masculino , Persona de Mediana Edad , Solución de Problemas , SemánticaRESUMEN
This study examined the treatment outcome of high-dose (1500 mg/day) zidovudine (AZT) on neuropsychological (NP) functioning (Trailmaking Test A & B, WAIS-R Digit Symbol, and Rey Auditory Verbal Learning Test) across a 12-month period in mildly symptomatic HIV-1 seropositive men (n = 46 at entry) enrolled in a randomized, double-blind, placebo-controlled trial (VA Cooperative Studies Program #298). Neither short-term (0-6 months) nor long-term (0-12 months) AZT administration revealed enhancement in NP performance. The results suggest that, although AZT may afford patients prophylactic benefits, protracted high-dose AZT treatment does not improve NP functioning in mildly symptomatic HIV-positive individuals.
Asunto(s)
Fármacos Anti-VIH/uso terapéutico , Trastornos del Conocimiento/diagnóstico , Trastornos del Conocimiento/etiología , Seropositividad para VIH/complicaciones , Seropositividad para VIH/tratamiento farmacológico , Zidovudina/uso terapéutico , Adulto , Fármacos Anti-VIH/administración & dosificación , Relación Dosis-Respuesta a Droga , Método Doble Ciego , Femenino , Estudios de Seguimiento , Humanos , Masculino , Pruebas Neuropsicológicas , Tiempo , Resultado del Tratamiento , Zidovudina/administración & dosificaciónRESUMEN
OBJECTIVE: To determine the ability of neonatal clinical, audiologic, and computed tomography (CT) findings to predict long-term neurodevelopmental outcome in children with symptomatic congenital cytomegalovirus (CMV) infection. METHODS: Longitudinal cohort study of children (n = 41) with symptomatic congenital CMV infection evaluated at birth and followed up with serial age-appropriate neurodevelopmental testing. The performance of birth characteristics as predictors of long-term outcome were determined, and clinical and CT scoring systems were developed and correlated with intellectual outcome. RESULTS: Microcephaly was the most specific predictor of mental retardation (100%; 95% CI 84.5-100) and major motor disability (92.3%; 95% CI 74.8-99). An abnormality detected by CT was the most sensitive predictor for mental retardation (100%; 95% CI 82.3-100) and motor disability (100%; 95% CI 78.2-100). A highly significant (P <.001) positive correlation was found between head size at birth and the intelligence/developmental quotient (IQ/DQ). Approximately 29% of children had an IQ/DQ >90. There was no association between sensorineural hearing loss at birth and cognitive outcome. However, children with sensorineural hearing loss on follow-up (congenital and late-onset) had a lower IQ/DQ (P =.006) than those with normal hearing. CONCLUSIONS: The presence of microcephaly at birth was the most specific predictor of poor cognitive outcome in children with symptomatic congenital CMV infection, whereas children with normal findings on head CT and head circumference proportional to weight exhibited a good cognitive outcome.
Asunto(s)
Infecciones por Citomegalovirus/congénito , Discapacidades del Desarrollo/virología , Enfermedades del Sistema Nervioso/virología , Parálisis Cerebral/diagnóstico , Parálisis Cerebral/virología , Coriorretinitis/diagnóstico , Coriorretinitis/virología , Infecciones por Citomegalovirus/complicaciones , Discapacidades del Desarrollo/diagnóstico , Femenino , Pérdida Auditiva Sensorineural/diagnóstico , Pérdida Auditiva Sensorineural/virología , Humanos , Recién Nacido , Discapacidad Intelectual/diagnóstico , Discapacidad Intelectual/virología , Estudios Longitudinales , Masculino , Microcefalia/diagnóstico , Microcefalia/virología , Enfermedades del Sistema Nervioso/diagnóstico , Examen Neurológico , Pronóstico , Sensibilidad y Especificidad , Tomografía Computarizada por Rayos XRESUMEN
El síndrome compartimental de las extremidades inferiores es una complicación secundaria a isquemia y a daño por reperfusión. El diagnóstico y tratamiento precoces son esenciales para evitar la progresión de las lesiones. Se presenta una paciente con síndrome compartimental de la extremidad inferior izquierda tras la canalización de arteria y vena femorales izquierdas para la realización de bypass cardiopulmonar (AU)
Compartment syndrome of the lower leg is an occasional complication of prolonged ischemia and reperfusion. We present a patient with compartment syndrome of the ipsilateral thigh after femoral arterial and venous cannulation for cardiopulmonary bypass (AU)